Smith & Nephew plc

    Jurisdiction
    United Kingdom
    LEI
    213800ZTMDN8S67S1H61
    ISIN
    GB0009223206 (SN.L)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    trending_flat 52 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    €21.86 40.9% undervalued
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €7.58B
    Gross margin
    70.0%
    EBIT
    €940.72M
    EBIT margin
    12.4%
    Net income
    €609.67M
    Net margin
    8.0%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €5.57B -26.5% €831.62M +36.4%
    €5.87B +5.3% €910.91M +9.5%
    €6.16B +5.0% €1.00B +9.8%

    Dividends

    Last dividend amount
    £11.17
    Ex date
    Payment date
    Dividend payout ratio
    75.0%

    Investor transactions

    Name Shares Value Last change Change type
    Ray Dalio 66K $1.86M -101K Sell

    Add to watchlist

    Notifications